Clarity Pharmaceuticals is a leading ASX listed clinical stage radiopharmaceutical company developing theranostic (therapy and imaging) products based on our platform SAR Technology. Our mission is to develop next-generation radiopharmaceutical products that improve treatment outcomes for children and adults with cancer. Clarity has a diverse range of products in clinical trials addressing both large indications (prostate cancer and breast cancer) as well as rare and orphan indications (neuroendocrine tumours (NETs) and neuroblastoma). We are currently growing our team to help facilitate the expansion of the company and are looking for talented people, motivated to take on new challenges and excited to grow with us. About the position The Head of Clinical Development (VP/SVP) is a pivotal leadership role responsible for shaping and driving global clinical development strategy across Clarity's oncology portfolio. The role ensures that programs are scientifically robust, commercially informed, and aligned with global regulatory expectations. The role provides senior oversight across clinical study design, execution, data interpretation, safety, vendor performance, data integrity, inspection readiness, and timely study close-out, ensuring studies are delivered to high standards of quality, compliance, and scientific integrity. Externally, the role will represent the company with regulatory authorities, investigators, KOLs, advisory boards, and scientific forums, while overseeing critical regulatory deliverables, including INDs, briefing books, Investigator’s Brochures and annual updates and monitoring emerging scientific, medical, and regulatory trends to keep development strategies current and fit for purpose. Key Responsibilities Lead global clinical development strategies aligned with regulatory, scientific, and commercial objectives. Drive program-level decision-making, lifecycle planning, and portfolio prioritization with executive leadership. Oversee key regulatory deliverables (e.g., INDs, briefing books, Investigator’s Brochures, annual updates). Serve as a senior representative with regulatory authorities (e.g., FDA). Monitor emerging scientific and regulatory trends to inform program strategy. Study Oversight Provide senior oversight of trial design, protocols, key study documents, SAPs, CSRs, and data review processes. Lead interpretation of clinical data to support development and governance decisions. Ensure robust safety oversight, vendor performance, data integrity, inspection readiness, and timely study close-out. Proactively identify and manage clinical and operational risks. External Engagement Build strategic relationships with investigators, KOLs, and advisory boards. Partner with Medical Affairs on external engagement initiatives. Represent the company at scientific and regulatory forums. Leadership Build, lead, and mentor a high-performing Clinical Development team. Set clear priorities, accountability, and decision-making frameworks. Foster a collaborative, high-performance, and continuous improvement culture. Operational Excellence Drive development and continuous improvement of clinical processes, standards, and SOPs. Education, Skills, and Experience You will Have PhD or advanced degree (Pharmacy, Nursing, MSc/MRes, or equivalent). 7+ years of clinical drug development or medical research experience in pharmaceutical or biotechnology settings. 5+ years of experience leading and developing diverse teams, including prior management experience. Strong understanding of global clinical development and regulatory pathways. Advanced knowledge of oncology clinical practice and emerging therapies. Proven leadership experience in matrixed, cross-functional environments. Excellent communication, problem-solving, and organizational skills. Proficient in Microsoft Office and electronic document systems. Ability to work flexibly across time zones as required. This role is open to candidates who have full eligibility to live and work in Australia. #J-18808-Ljbffr